<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.2"?>
<!-- generated-on="2026-04-19T09:40:36+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.2" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://news.medxy.ai/genetic-variant-diet-glucose/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T20:44:23-07:00</news:publication_date><news:title>Genetic Variant Modulates Dietary Impact on Glucose Control: Inuit Study Reveals Key Insights</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ata-risk-stratification-papillary-thyroid/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T20:41:18-07:00</news:publication_date><news:title>Validation of the 2025 ATA Risk Stratification System in a Cohort of Patients with Papillary Thyroid Carcinoma</news:title></news:news></url>
<url><loc>https://news.medxy.ai/2025-ata-risk-stratification-thyroid-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T20:28:01-07:00</news:publication_date><news:title>2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/lbbp-vs-bivp-death-rate-reduction/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-18T15:21:29-07:00</news:publication_date><news:title>LBBP优于BiVP：3年内死亡或心力衰竭住院率降低74%</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/lbbp-vs-bivp-risk-decrease/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-18T15:20:26-07:00</news:publication_date><news:title>LBBPがBiVPを上回る：3年間で死亡または心不全入院のリスクが74%減少</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/lbbp-vs-bivp-heart-failure/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-18T15:17:25-07:00</news:publication_date><news:title>LBBP vượt trội hơn BiVP: Giảm 74% tỷ lệ tử vong hoặc nhập viện do suy tim sau 3 năm</news:title></news:news></url>
<url><loc>https://news.medxy.ai/lbbp-vs-bivp-hospitalization-reduction/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T15:14:56-07:00</news:publication_date><news:title>LBBP Outperforms BiVP: 74% Reduction in Death or Heart Failure Hospitalization at 3 Years</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/cardiovascular-risk-increase/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-18T14:11:09-07:00</news:publication_date><news:title>心血管风险增加六倍：子痫早期产后威胁亟需临床关注</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/cardiovascular-risk-preeclampsia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-18T14:09:39-07:00</news:publication_date><news:title>心血管リスクが6倍に: 産褥期早期の子癇前症の脅威は緊急の臨床的な注意を必要とする</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/high-cardiac-risk/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-18T14:07:40-07:00</news:publication_date><news:title>Nguy cơ tim mạch cao gấp sáu lần: Đe dọa sớm sau sinh của tiền sản giật đòi hỏi sự chú ý lâm sàng khẩn cấp</news:title></news:news></url>
<url><loc>https://news.medxy.ai/eclampsia-postpartum-risk/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T14:04:03-07:00</news:publication_date><news:title>Six-Fold Higher Cardiovascular Risk: Eclampsia&#8217;s Early Postpartum Threat Demands Urgent Clinical Attention</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/no-clear-winner-glp-1-sglt2-benefits/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-18T13:39:35-07:00</news:publication_date><news:title>无明显胜者：真实世界证据显示GLP-1受体激动剂和SGLT2抑制剂在2型糖尿病中提供相当的心血管获益</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/no-clear-winner-glp-1-sglt2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-18T13:37:44-07:00</news:publication_date><news:title>明確な勝者はいない：実世界の証拠がGLP-1受容体作動薬とSGLT2阻害薬が2型糖尿病で同等の心血管効果を示す</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/no-clear-winner/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-18T13:33:25-07:00</news:publication_date><news:title>Không có người chiến thắng rõ ràng: Bằng chứng thực tế cho thấy GLP-1RAs và SGLT2 Inhibitors mang lại lợi ích tim mạch tương đương trong bệnh đái tháo đường tuýp 2</news:title></news:news></url>
<url><loc>https://news.medxy.ai/glp-1ra-vs-sglt2-benefits/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T13:30:30-07:00</news:publication_date><news:title>No Clear Winner: Real-World Evidence Shows GLP-1RAs and SGLT2 Inhibitors Deliver Comparable Cardiovascular Benefits in Type 2 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/wnt5a-actin-imbalance-lmna-heart-disease/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-18T12:18:37-07:00</news:publication_date><news:title>突破性研究揭示 WNT5a 驱动的肌动蛋白失调是 LMNA 相关心脏疾病的中心机制</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/wnt5a-actin-disruption-lmna-heart-disease/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-18T12:16:51-07:00</news:publication_date><news:title>革新的研究揭示WNT5a驱动的肌动蛋白失调是LMNA相关心脏疾病的中心机制</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/wnt5a-actin-disruption-cardiac-disease/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-18T12:15:26-07:00</news:publication_date><news:title>Nghiên cứu đột phá tiết lộ sự mất điều chỉnh actin do WNT5a là cơ chế cốt lõi trong bệnh tim liên quan đến LMNA</news:title></news:news></url>
<url><loc>https://news.medxy.ai/wnt5a-actin-dysregulation-cardio/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T12:12:26-07:00</news:publication_date><news:title>Breakthrough Study Reveals WNT5a-Driven Actin Dysregulation as Core Mechanism in LMNA-Related Cardiac Disease</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/fdg-pet-survival-breast-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-18T11:59:00-07:00</news:publication_date><news:title>早期FDG-PET预测转移性乳腺癌生存结果：IMPACT-MBC试验揭示快速反应成像作为强大预后工具</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/fdg-pet-breast-cancer-survival/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-18T11:57:51-07:00</news:publication_date><news:title>早期FDG-PET予測転移性乳がんの生存結果：IMPACT-MBC試験、迅速反応イメージングを強力な予後ツールとして明らかにする</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/fdg-pet-breast-cancer-prediction/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-18T11:56:13-07:00</news:publication_date><news:title>FDG-PET sớm dự đoán kết quả sống sót trong ung thư vú di căn: Thử nghiệm IMPACT-MBC tiết lộ hình ảnh đáp ứng nhanh là công cụ tiên lượng mạnh mẽ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/early-fdg-pet-survival/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T11:53:14-07:00</news:publication_date><news:title>Early FDG-PET Predicts Survival Outcomes in Metastatic Breast Cancer: IMPACT-MBC Trial Reveals Rapid Response Imaging as a Powerful Prognostic Tool</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/cubn-gene-mutations-vita-b12-deficiency/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-17T22:11:17-07:00</news:publication_date><news:title>CUBN基因中的遗传变异被确定为二甲双胍诱发维生素B12缺乏的关键风险因素</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/cubn-gene-mutation-risk/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-17T22:08:53-07:00</news:publication_date><news:title>CUBN遺伝子の変異がメトホルミン誘発ビタミンB12欠乏症の主要なリスク因子として同定</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/cubn-gene-mutation-vitamin-b12/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-17T22:07:03-07:00</news:publication_date><news:title>Đột biến gen CUBN được xác định là yếu tố nguy cơ chính gây thiếu vitamin B12 do metformin</news:title></news:news></url>
<url><loc>https://news.medxy.ai/cubn-gene-risk-factor/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-17T22:02:33-07:00</news:publication_date><news:title>Genetic Variant in CUBN Gene Identified as Key Risk Factor for Metformin-Induced Vitamin B12 Deficiency</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/testosterone-exercise-benefits/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-17T22:00:18-07:00</news:publication_date><news:title>睾酮增强运动在脊髓损伤患者中显示对肌肉质量和贫血有前景</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/testosterone-exercise-muscle-anemia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-17T21:58:49-07:00</news:publication_date><news:title>脊髄損傷患者におけるテストステロンを補助とした運動が筋量と貧血に有望な結果</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/testosterone-and-exercise-benefits/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-17T21:57:05-07:00</news:publication_date><news:title>Việc Tập Thể Dục Được Tăng Cường Bằng Testosterone Hiển Thị Hứa Hẹp cho Khối Cơ và Thiếu Máu ở Bệnh Nhân Chấn Thương Tủy Sống</news:title></news:news></url>
<url><loc>https://news.medxy.ai/testosterone-exercise-muscle-anemia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-17T21:53:16-07:00</news:publication_date><news:title>Testosterone-Augmented Exercise Shows Promise for Muscle Mass and Anemia in Spinal Cord Injury Patients</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/maternal-diabetes-developmental-effects/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-17T21:49:14-07:00</news:publication_date><news:title>母体糖尿病与早期神经发育：糖尿病类型对后代发展里程碑的差异性影响</news:title></news:news></url>
<url><loc>https://news.medxy.ai/maternal-diabetes-neurodevelopment/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-17T21:23:36-07:00</news:publication_date><news:title>Maternal Diabetes and Early Neurodevelopment: Differential Risks Emerge Across Diabetes Types and Infant Sex</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/myocardial-fibrosis-aortic-stenosis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-17T21:20:00-07:00</news:publication_date><news:title>心肌纤维化预测无症状重度主动脉瓣狭窄患者的预后，但早期瓣膜置换可能并非普遍受益</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/aortic-stenosis-prognosis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-17T21:18:01-07:00</news:publication_date><news:title>無症狀重度大動脈弁狭窄症における心筋線維化が予後を予測するが、早期弁置換は普遍的な利益をもたらさない可能性がある</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/heart-failure-prediction-aortic-regurgitation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-17T21:15:51-07:00</news:publication_date><news:title>Xơ cơ tim dự đoán kết quả ở bệnh nhân hở van động mạch chủ nặng không triệu chứng, nhưng thay van sớm có thể không mang lại lợi ích phổ quát</news:title></news:news></url>
<url><loc>https://news.medxy.ai/myocardial-fibrosis-aortic-stenosis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-17T21:12:56-07:00</news:publication_date><news:title>Myocardial Fibrosis Predicts Outcomes in Asymptomatic Severe Aortic Stenosis, But Early Valve Replacement May Not Offer Universal Benefit</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/shear-stress-endothelial-signal-pathway/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-04-17T20:15:05-07:00</news:publication_date><news:title>剪切应力诱导的内皮HEG1信号通路：连接血流与血压调节的新途径</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/shear-stress-endothelial-signaling/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-04-17T20:13:38-07:00</news:publication_date><news:title>せん断応力誘導内皮細胞HEG1シグナル伝達：血流と血圧制御を結ぶ新たな経路</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/heg1-signal-blood-pressure/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-04-17T20:10:58-07:00</news:publication_date><news:title>Căng thẳng cắt gây ra tín hiệu nội mô HEG1: Một con đường mới liên kết lưu lượng máu với điều chỉnh huyết áp</news:title></news:news></url>
<url><loc>https://news.medxy.ai/shear-stress-endothelial-signalling/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-17T20:07:53-07:00</news:publication_date><news:title>Shear Stress-Induced Endothelial HEG1 Signalling: A Novel Pathway Linking Blood Flow to Blood Pressure Regulation</news:title></news:news></url>
</urlset>
